诺和诺德CEO将卸任,成也GLP-1,败也GLP-1!

药事纵横
20 May

5月16日,全球制药巨头诺和诺德发布公告:执掌公司八年的CEO Lars Fruergaard Jørgensen将卸任。这位曾带领公司实现销售额、利润和股价三倍增长的丹麦老将,竟以“被董事会共同决定”的方式黯然离场,成为诺和诺德自1960年以来首位非主动卸任的CEO。约根森在电话会议中坦言,自己也是“最近才得知消息”……Jørgensen见证了诺和诺德的崛起,也见证了大大小小的危机。自1991年...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10